TMA Executive Director celebrated

At the recent annual meeting of the International Myositis Assessment and Clinical Studies Group (IMACS) in Chicago, more than 130 international myositis experts joined in recognizing TMA’s retiring Executive Director Bob Goldberg. The meeting’s participants reflected on Bob’s leadership and commitment to the myositis patient and research community over the last 16 years, which have…

Continue Reading
Mother and Daughter Hugging

Lenabasum questions answered

Excitement is building for Corbus Pharmaceutical’s Phase 3 clinical trial testing the safety and effectiveness of their new drug lenabasum in dermatomyositis patients.

Continue Reading
Doctor Working on Computer

Research grants awarded

The Myositis Association announces the awarding of three new research grants to fund basic and applied investigations in myositis diseases. Since 2002, TMA’s research funding program has awarded 37 grants and 19 research fellowships, totaling nearly $7 million. The following myositis research projects were recommended for funding by the TMA’s Medical Advisory Board and approved…

Continue Reading